DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ advanced 2.27% to $7.65 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.26% to 27,122.09 and the Dow Jones Industrial Average rising 0.71% to 52,048.83.
This was the stock's second consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 62.79% short of its 52-week high of $20.56, which the company achieved on October 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 0.49% to $5.16, Fortress Biotech Inc. (FBIO) fell 3.98% to $2.41, and Viking Therapeutics Inc. (VKTX) rose 3.86% to $30.11.
Trading volume (498,643) remained 246,938 below its 50-day average volume of 745,581.
Data source: Dow Jones Market Data, FactSet. Data compiled September 21, 2026.